Back
Larimar Therapeutics Vs. G1 Therapeutics Industry Stock Comparison
Buy
66
LRMR
Larimar Therapeutics
Last Price:
7.14
Seasonality Move:
-20.55%
Buy
59
GTHX
G1 Therapeutics
Last Price:
4.78
Seasonality Move:
24.94%
Buy
66
Larimar Therapeutics (LRMR)
is a Buy
Is Larimar Therapeutics a Buy, Sell or Hold?
- The current Larimar Therapeutics [LRMR] share price is $7.12. The Score for LRMR is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- LRMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
G1 Therapeutics (GTHX)
is a Buy
Is G1 Therapeutics a Buy, Sell or Hold?
- The current G1 Therapeutics [GTHX] share price is $4.77. The Score for GTHX is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- GTHX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LRMR Stock Price Chart
What is Larimar Therapeutics's stock price today?
-
The Larimar Therapeutics share price today is $7.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LRMR is experiencing selling pressure, which indicates risk of future bearish movement.
GTHX Stock Price Chart
What is G1 Therapeutics's stock price today?
-
The G1 Therapeutics share price today is $4.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GTHX is experiencing selling pressure, which indicates risk of future bearish movement.
LRMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 45.57 | Sell |
| Chaikin Money Flow: | -329572 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.53 - 7.67) | Buy |
| Bollinger Bands (100): | (4.82 - 9.76) | Sell |
GTHX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 60.5 | Buy |
| Chaikin Money Flow: | -1212626 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.97 - 4.65) | Buy |
| Bollinger Bands (100): | (2.95 - 4.45) | Buy |
LRMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.75 | Sell |
| 20-day SMA: | 7.11 | Buy |
| 50-day SMA: | 7.94 | Sell |
| 200-day SMA: | 5.43 | Buy |
| 8-day EMA: | 7.56 | Sell |
| 20-day EMA: | 7.39 | Sell |
| 50-day EMA: | 7.52 | Sell |
| 200-day EMA: | 6.13 | Buy |
GTHX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.45 | Buy |
| 20-day SMA: | 4.21 | Buy |
| 50-day SMA: | 4.08 | Buy |
| 200-day SMA: | 2.71 | Buy |
| 8-day EMA: | 4.48 | Buy |
| 20-day EMA: | 4.31 | Buy |
| 50-day EMA: | 4.06 | Buy |
| 200-day EMA: | 3.45 | Buy |
Larimar Therapeutics Earnings Growth & LRMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.55 per share, and a decrease next year of $0.24 per share.
G1 Therapeutics Earnings Growth & GTHX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.19 per share, an increase next quarter of $0.08 per share, an increase this year of $0.30 per share, and an increase next year of $0.36 per share.
Larimar Therapeutics Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
G1 Therapeutics Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||